. Afssaps, Recommandations à destination des biologistes concernant la spécificité des dosages de vitamine D, 1922.

S. Zuniga, Vitamin D and the vitamin D receptor in liver pathophysiology, Clinics and Research in Hepatology and Gastroenterology, vol.35, issue.4, pp.295-302, 2002.
DOI : 10.1016/j.clinre.2011.02.003

J. J. Heidelbaugh, M. D. , M. Bruderly, and M. D. , Cirrhosis and Chronic Liver Failure : Part I. Diagnosis and Evaluation. American academy of family physicians, pp.756-762, 2006.

D. A. Hughes, R. Norton, D. Vitamin, L. M. Respiratory-health-bodnar, M. A. Krohn et al., Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner, Clin Exp Immunol. J Nutr. Hepatology, vol.158, issue.13961, pp.56-105, 1928.

A. H. Rahman, A. D. Branch, M. T. , and S. K. Roberts, Vitamin D for your patients with chronic hepatitis C? D-livering the message: the importance of vitamin D status in chronic liver disease, J Hepatol. J Hepatol, vol.58, issue.574, pp.897-909, 2012.

S. Abu-mouch, Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-na??ve patients, World Journal of Gastroenterology, vol.17, issue.47, 2011.
DOI : 10.3748/wjg.v17.i47.5184

J. P. Viard, Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study, AIDS, vol.25, issue.10, pp.1305-1320, 2011.
DOI : 10.1097/QAD.0b013e328347f6f7

E. Villamor, A Potential Role for Vitamin D on HIV Infection?, Nutrition Reviews, vol.64, issue.5, pp.226-259, 2006.
DOI : 10.1111/j.1753-4887.2006.tb00205.x

A. F. Gombart, The vitamin D???antimicrobial peptide pathway and its role in protection against infection, Future Microbiology, vol.4, issue.9, 2009.
DOI : 10.2217/fmb.09.87

E. Hypponen, Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study, The Lancet, vol.358, issue.9292, pp.358-1500, 2001.
DOI : 10.1016/S0140-6736(01)06580-1

A. Giulietti, Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice, Diabetologia, vol.47, issue.3, pp.451-62, 1936.
DOI : 10.1007/s00125-004-1329-3

K. L. Munger, Preclinical Serum 25-Hydroxyvitamin D Levels and Risk of Type 1 Diabetes in a Cohort of US Military Personnel, American Journal of Epidemiology, vol.177, issue.5, pp.411-420, 2013.
DOI : 10.1093/aje/kws243

N. G. Forouhi, Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies, Diabetologia, vol.34, issue.Suppl 1, pp.55-2173, 2012.
DOI : 10.1007/s00125-012-2544-y

A. Zittermann, J. F. Gummert, and J. Borgermann, Vitamin D deficiency and mortality, Current Opinion in Clinical Nutrition and Metabolic Care, vol.12, issue.6, pp.634-643, 2009.
DOI : 10.1097/MCO.0b013e3283310767

P. Lee, J. A. Eisman, and J. R. Center, Vitamin D Deficiency in Critically Ill Patients, New England Journal of Medicine, vol.360, issue.18, pp.1912-1916, 2009.
DOI : 10.1056/NEJMc0809996

G. Bjelakovic, Vitamin D supplementation for prevention of mortality in adults, Cochrane Database Syst Rev, issue.7, 2011.

L. Rejnmark, Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease, J Clin Endocrinol Metab. Liver Int, vol.42, issue.325, pp.97-845, 1943.

G. Targher, Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease, Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease LAVOISIER. 48. HAS, Critères diagnostiques et bilan initial de la cirrhose non compliquée. Décembre. 51. PATERON, D., Infections bactériennes sévères du cirrhotique. réan. urg, pp.517-541, 1995.
DOI : 10.1016/j.numecd.2006.04.002

V. Arvaniti, Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis Compensated cirrhosis: natural history and prognostic factors, Gastroenterology. Hepatology, vol.139, issue.71, pp.1246-56, 1987.

H. G. Adams and C. Jordan, Infections in the Alcoholic, Medical Clinics of North America, vol.68, issue.1, pp.179-200, 1984.
DOI : 10.1016/S0025-7125(16)31249-4

R. Wiest, A. Krag, and A. Gerbes, Spontaneous bacterial peritonitis: recent guidelines and beyond, Gut, vol.61, issue.2, p.61, 2011.
DOI : 10.1136/gutjnl-2011-300779

URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.652.4862

J. Lata, O. Stiburek, and M. Kopacova, Spontaneous bacterial peritonitis: A severe complication of liver cirrhosis, World Journal of Gastroenterology, vol.15, issue.44, pp.15-5505, 2009.
DOI : 10.3748/wjg.15.5505

S. Y. Chen, Impact of liver cirrhosis on mortality in patients with communityacquired bacteremia Recurrence of spontaneous bacterial peritonitis in cirrhotic patients non-prophylactically treated with norfloxacin: serum albumin as an easy but reliable predictive factor Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis, Diagn Microbiol Infect Dis. Liver Int. N Engl J Med, vol.64, issue.2217, pp.31-184, 1994.

G. Tritto, Evidence of neutrophil functional defect despite inflammation in stable cirrhosis, Journal of Hepatology, vol.55, issue.3, pp.574-81, 2011.
DOI : 10.1016/j.jhep.2010.11.034

F. J. Laso, Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption, Hepatology, vol.25, issue.5, pp.1096-100, 1997.
DOI : 10.1002/hep.510250508

C. Silvain, Immunit?? inn??e, Toll-like r??cepteurs et cirrhose, Gastroent??rologie Clinique et Biologique, vol.29, issue.4, pp.480-481, 2005.
DOI : 10.1016/S0399-8320(05)80825-5

E. T. Tsiaousi, Malnutrition in end stage liver disease: Recommendations and nutritional support, Journal of Gastroenterology and Hepatology, vol.3, issue.4, pp.527-560, 2005.
DOI : 10.1016/S1386-6346(01)00105-X

B. Campillo, Evaluation of nutritional practice in hospitalized cirrhotic patients, Nutrition, vol.19, issue.6, pp.515-536, 2003.
DOI : 10.1016/S0899-9007(02)01071-7

M. Malham, The effect of a single oral megadose of vitamin D provided as either ergocalciferol (D(2)) or cholecalciferol (D(3)) in alcoholic liver cirrhosis Vitamin D in chronic liver disease, Eur J Gastroenterol Hepatol. Liver Int, vol.24, issue.333, pp.338-52, 2012.

B. Campillo, J. P. Richardet, and P. N. Bories, Validation of body mass index for the diagnosis of malnutrition in patients with liver cirrhosis, Gastroent??rologie Clinique et Biologique, vol.30, issue.10, pp.30-1137, 2006.
DOI : 10.1016/S0399-8320(06)73491-1

B. Campillo, Value of body mass index in the detection of severe malnutrition: influence of the pathology and changes in anthropometric parameters, Clinical Nutrition, vol.23, issue.4, pp.551-560, 2004.
DOI : 10.1016/j.clnu.2003.10.003

J. S. Bajaj, Second infections independently increase mortality in hospitalized patients With cirrhosis: the north american consortium for the study of end-stage liver disease (NACSELD) experience, Hepatology, vol.305, issue.Suppl 1, pp.2328-2363, 2012.
DOI : 10.1002/hep.25947

J. J. Heidelbaugh and M. Bruderly, Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation, Am Fam Physician, vol.74, issue.5, pp.756-62, 2006.

K. M. Fleming, Incidence and prevalence of cirrhosis in the United Kingdom, 1992???2001: A general population-based study, Journal of Hepatology, vol.49, issue.5, 2008.
DOI : 10.1016/j.jhep.2008.05.023

K. M. Fleming, All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study, Liver International, vol.43, issue.1, pp.79-84, 2011.
DOI : 10.1111/j.1478-3231.2011.02517.x

M. Borzio, Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study, Digestive and Liver Disease, vol.33, issue.1, pp.41-49, 2001.
DOI : 10.1016/S1590-8658(01)80134-1

J. B. Saunders, A 20-year prospective study of cirrhosis., BMJ, vol.282, issue.6260, pp.263-269, 1981.
DOI : 10.1136/bmj.282.6260.263

G. Garcia-tsao, Bacterial infections in cirrhosis: treatment and prophylaxis, Journal of Hepatology, vol.42, issue.1, pp.42-85, 2005.
DOI : 10.1016/j.jhep.2004.12.006

J. Fernandez, Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis Bacterial infections in patients with cirrhosis: reasons, comments and suggestions, 78. Navasa, M, pp.140-148, 2001.

S. Ghassemi and G. Garcia-tsao, Prevention and treatment of infections in patients with cirrhosis, Best Practice & Research Clinical Gastroenterology, vol.21, issue.1, pp.77-93, 2007.
DOI : 10.1016/j.bpg.2006.07.004

C. Zhang, Vitamin D Status and Expression of Vitamin D Receptor and LL-37 in Patients with Spontaneous Bacterial Peritonitis, Digestive Diseases and Sciences, vol.182, issue.1, 2011.
DOI : 10.1007/s10620-011-1824-6

M. Merli, O. Riggio, and L. Dally, Does malnutrition affect survival in cirrhosis?, Hepatology, vol.23, issue.5, pp.1041-1047, 1996.
DOI : 10.1002/hep.510230516

U. E. Schaible and S. H. Kaufmann, Malnutrition and Infection: Complex Mechanisms and Global Impacts, e115. 83. CHANDRA, R.K., Nutrition and the immun system. A993, 2007.
DOI : 10.1371/journal.pmed.0040115.sd003

S. H. Pearce, T. D. Cheetham-bischoff-ferrari, and H. A. , Diagnosis and management of vitamin D deficiency 340:b5664.(doi): p. 10.1136/bmj.b5664 Estimation of optimal serum concentrations of 25- hydroxyvitamin D for multiple health outcomes Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol, Bmj. Am J Clin Nutr. Am J Clin Nutr, vol.85, issue.861, pp.18-28, 2003.

P. Bergman, Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study, BMJ Open, issue.26, 2012.

D. R. Murdoch, Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren, Jama. Am J Clin Nutr, vol.308, issue.135, pp.91-1255, 2010.

M. T. Kitson, Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection EASL Clinical Practice Guidelines: management of cholestatic liver diseases Oral vitamin D replacement is effective in chronic liver disease, J Hepatol. J Hepatol. Gastroenterol Clin Biol, vol.58, issue.51211, pp.467-72, 2009.